Skip to main content
Proceedings (Baylor University. Medical Center) logoLink to Proceedings (Baylor University. Medical Center)
. 2019 Sep 18;32(4):607–609. doi: 10.1080/08998280.2019.1651149

Functional neurological symptoms masquerading as Wernicke encephalopathy following bariatric surgery

Andrew M Kiselica a,✉, Sabra Rosen a, Jared F Benge a,b,c
PMCID: PMC6794007  PMID: 31656438

Abstract

Wernicke encephalopathy (WE), caused by thiamine deficiency, is classically associated with alcoholism but is increasingly recognized among patients who have undergone bariatric surgery. As with other neurocognitive conditions, alternative explanations for symptoms, such as psychiatric, neurological, and motivational factors, must be considered before arriving at a diagnosis of WE. We present a patient after sleeve gastrectomy who was presumed to have WE; after detailed neuropsychological assessment, the condition was better conceptualized as a conversion disorder. The case illustrates the heretofore unrecognized role of bariatric surgery in the development of functional symptoms and demonstrates the importance of neuropsychological assessment in detecting functional symptoms.

Keywords: Bariatric surgery, conversion disorder, neuropsychology, somatic symptom disorder, Wernicke encephalopathy


Wernicke encephalopathy (WE) is caused by thiamine deficiency and is clinically diagnosed by the presence of at least two of the following: (1) evidence of dietary deficiency by laboratory results or history; (2) oculomotor abnormalities (e.g., nystagmus); (3) cerebellar dysfunction (e.g., ataxia, dysmetria); and (4) altered mental status or mild memory impairment.1,2 WE is increasingly recognized in bariatric surgery patients,3 although diagnosis may be complicated by psychiatric factors. In a patient who had undergone sleeve gastrectomy, we present a case of presumed WE that was found to be a conversion disorder.

CASE DESCRIPTION

A 36-year-old right-handed white preschool teacher with 16 years of education had undergone sleeve gastrectomy at an outside hospital 11 months prior to the current evaluation. Per her report, she had not received a presurgical behavioral health evaluation. Her husband indicated that she had an excellent recovery in the 4 to 6 weeks following the surgery. She subsequently developed acute memory loss, disorientation, dizziness, nausea, vomiting, ataxia, and repeated falls. The operating surgeon advised the patient to go for vitamin infusions and parenteral B1 injections due to suspicion of WE. Infusions did not result in permanent resolution of symptoms, such that the patient presented to another hospital about 2 months later. A head computed tomography scan was read as normal, and the patient was discharged the same day with recommendation to follow up with neurology.

Blood tests nearly 3 months after surgery revealed vitamin B12 (917 pg/mL) and elevated B1 (209 nmol/L) within normal limits. She followed up with outpatient neurology with improved symptoms, a normal neurologic exam, and a 29/30 on the Mini-Mental Status Exam. The provider recommended no further intervention. The patient was dissatisfied with this visit and canceled all follow-up appointments with the neurologist.

She followed up with a different neurologist 10 months after surgery. Her B12 level was 1790 pg/mL, and her B1 level was 288 nmol/L. The patient reported arm tremors, memory loss, stuttering, word-finding difficulties, problems with self-expression, and intermittent hand and feet numbness. Montreal Cognitive Assessment at this visit was 18/30. The provider ordered magnetic resonance imaging of the brain and an electroencephalogram, which were both read as normal.

At follow-up with neurology 11 months after surgery, the provider discussed the normal laboratory, neuroimaging, and electroencephalogram findings and suggested that the presenting problems were attributable to anxiety. She and her spouse again expressed dissatisfaction with his explanation. The patient was referred for neuropsychological evaluation and seen 11 months postoperatively.

Cognitively, the patient reported attention, language, visuospatial, memory, and executive problems. The patient’s husband questioned whether her symptoms might be consistent with “Wernicke-Korsakoff’s” and implied that fluctuations in cognition appeared to be correlated with missed doses of thiamine. Functionally, she reported that she was able to complete basic activities of daily living without difficulty but noted dependence for most complex tasks. Her husband had taken over all driving and was managing her medications, finances, and medical appointments due to mistakes made by the patient. While still employed as a preschool teacher, the patient was planning to leave her job in the next week and was considering applying for disability.

Regarding psychiatric symptoms, she reported that she was raped as a teenager with a subsequent suicide attempt and a 3-day inpatient psychiatric hospitalization. The patient described having bouts of re-experiencing symptoms related to this event, as well as depression and anxiety, on and off for her whole life. She noted that she has been on psychiatric medications and participated in therapy intermittently since the sexual assault but was not currently receiving treatment. At the current evaluation, she reported some depression but denied suicidal ideation and self-injurious behavior. Table 1 provides a summary of neuropsychological test data.

Table 1.

The patient’s neuropsychological test results

Test domain Raw score Percentile Descriptora/ interpretation
Performance validity      
 TOMM trial 1 31 — Suggestive of invalid performance
 TOMM trial 2 43 — Suggestive of invalid performance
 TOMM retention 36 — Suggestive of invalid performance
 Reliable digit span 5 — Suggestive of invalid performance
 CVLT-II: forced choice 14 — Suggestive of invalid performance
Motor speed      
 GPB dominant hand 81 4 Low score
 GPB nondominant hand 87   Below average score
Attention      
 WAIS-IV digit span 13 1 Extremely low score
Processing speed      
 Trail Making Test part A 53 1 Extremely low score
 Stroop word reading 47 <1 Extremely low score
 Stroop color naming 40 <1 Extremely low score
Language      
 BNT-30 21 <1 Extremely low score
 Animal fluency 8 <1 Extremely low score
Visuospatial      
 NAB VisD 12 <1 Extremely low score
 BVMT copy 12/12 — Intact
Memory      
 BVMT trials 1–3 total 13 1 Extremely low score
 BVMT delayed recall 5 <1 Extremely low score
 BVMT recognition 3 <1 Extremely low score
 CVLT-II trials 1–5 total 22 <1 Extremely low score
 CVLT-II short-delay recall 2 <1 Extremely low score
 CVLT-II long-delay recall 3 <1 Extremely low score
 CVLT-II recognition 1.20 <1 Extremely low score
 WMS-IV LM I 13 <1 Extremely low score
 WMS-IV LM II 9 <1 Extremely low score
 WMS-IV LM recognition 19 3–9 Low score
Executive functioning      
 COWA 20 1 Extremely low score
 MWCST 6 54 Average
 Trail Making Test part B 115 1 Extremely low score
 Stroop inhibition 16 <1 Extremely low score
Emotional functioning      
 BDI-2 25 — Moderate depression
 GAD-7 12 — Moderate anxiety
Personality functioning      
 MMPI-II-RF RBSb 14 >99 Possible overreporting; invalid profile

aDescriptors for cognitive variables based on consensus recommendations.13

bBecause item responses yielded an invalid profile, remaining scores are not presented.

BDI-2 indicates Beck Depression Inventory–second edition; BNT-30, Boston Naming Test, 30-item version; BVMT, Brief Visuospatial Memory Test; COWA, Controlled Oral Word Association; CVLT-II, California Verbal Learning Test–second edition; GAD-7, Generalized Anxiety Disorder-7; GPB, grooved pegboard; MMPI-II-RF RBS, NAB Minnesota Multiphasic Personality Questionnaire-2-Restructured Form Response Bias Scale; MWCST, Modified Wisconsin Card Sorting Test; TOMM, Test of Memory Malingering; VisD, Neuropsychological Assessment Battery–Visual Discrimination; WAIS-IV, Wechsler Adult Intelligence Scale–Fourth Edition; WMS-IV LM, Wechsler Memory Scale–Fourth Edition–Logical Memory.

DISCUSSION

As shown in Table 1, the patient’s scores on performance validity indicators were below the recommended cut points to suggest invalid performance. Additionally, she demonstrated a tendency to report more symptoms than individuals with actual medical conditions. Importantly, her performance on cognitive tests was inconsistent with her report of daily functioning. For instance, her low scores were consistent with performance of an individual with moderate-stage dementia, while she continued to work.

Test findings, combined with normal neuroimaging, electroencephalogram, and laboratory results, suggested that the patient’s presentation was not consistent with neurological damage. WE seemed unlikely, given the absence of observed oculomotor abnormalities, gait disturbances, dyscoordination, or evidence of thiamine deficiency. Rather, her symptoms may best be conceptualized as a conversion disorder.4 This diagnosis is consistent with prior research. She reported an extensive psychiatric history and recent stressful life events, two important risk factors for developing medically unexplained symptoms.5–7 Additionally, she demonstrated heavy health care resource utilization8 and disavowed psychiatric explanations for her symptoms in favor of more traditionally “organic” explanations.9

This case has important implications for clinical practice. It highlights the importance of presurgical psychological evaluations, which are recommended in practice guidelines from the American Society for Metabolic and Bariatric Surgery10 and may have prevented decompensation and debility in this case. Second, this report illustrates the potential utility of including symptom validity tests in presurgical evaluations. Importantly, these measures are embedded in existing personality tests often used in clinical practice,11 such as the Minnesota Multiphasic Personality Inventory. Performance validity measures (e.g., the Test of Memory Malingering) may also be useful when making bariatric presurgical recommendations, a possibility being explored for other types of surgical interventions.12

ACKNOWLEDGMENTS

The authors thank Heather Flores for assistance in obtaining, scoring, and collating test data for this patient.

References

  • 1.Caine D, Halliday G, Kril J, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62:51–60. doi: 10.1136/jnnp.62.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17:1408–1418. doi: 10.1111/j.1468-1331.2010.03153.x. [DOI] [PubMed] [Google Scholar]
  • 3.Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008;248:714–720. doi: 10.1097/SLA.0b013e3181884308. [DOI] [PubMed] [Google Scholar]
  • 4.American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013. [Google Scholar]
  • 5.Pareés I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci. 2014;338:174–177. doi: 10.1016/j.jns.2013.12.046. [DOI] [PubMed] [Google Scholar]
  • 6.Aybek S, Nicholson TR, Zelaya F, et al. Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry. 2014;71:52–60. doi: 10.1001/jamapsychiatry.2013.2842. [DOI] [PubMed] [Google Scholar]
  • 7.Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain. 2010;133:1537–1551. doi: 10.1093/brain/awq068. [DOI] [PubMed] [Google Scholar]
  • 8.De Waal MWM, Arnold IA, Eekhof JAH, et al. Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care. BMC Fam Pract. 2008;9:8. doi: 10.1186/1471-2296-9-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boone KB, ed. Neuropsychological Evaluation of Somatoform and Other Functional Somatic Conditions: Assessment Primer. New York, NY: Routledge; 2017. [Google Scholar]
  • 10.Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12:731–749. doi: 10.1016/j.soard.2016.02.008. [DOI] [PubMed] [Google Scholar]
  • 11.Marek RJ, Heinberg LJ, Lavery M, et al. A review of psychological assessment instruments for use in bariatric surgery evaluations. Psychol Assess. 2016;28:1142–1157. doi: 10.1037/pas0000286. [DOI] [PubMed] [Google Scholar]
  • 12.Rossetti MA, Collins RL, York MK. Performance validity in deep brain stimulation candidates. Arch Clin Neuropsychol. 2018;33:508–514. doi: 10.1093/arclin/acx081. [DOI] [PubMed] [Google Scholar]
  • 13.Guilmette T, Sweet J. Statement on Uniform Test Score Labeling of Performance Tests. American Academy of Clinical Neuropsychology Consensus Conference. San Diego, CA: American Academy of Clinical Neuropsychology; 2018. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings (Baylor University. Medical Center) are provided here courtesy of Baylor University Medical Center

RESOURCES